Larvol Delta - Alzamend-Neuro-Receives-FDA-Study-May-Proceed-Notication-for-a-Phase-IIA-Clinical-Trial-of-AL001-a-NextGeneration-Lithium-Therapeutic-Drug-Candidate-in-Bipolar-Disorder-Patients

LISPRO (lithium/proline/salicylate) - Alzamend Neuro

https://www.businesswire.com/news/home/20231002933625/en/Alzamend-Neuro-Receives-FDA-%E2%80%9CStudy-May-Proceed%E2%80%9D-Notification-for-a-Phase-IIA-Clinical-Trial-of-AL001-a-Next-Generation-Lithium-Therapeutic-Drug-Candidate-in-Bipolar-Disorder-Patients

Oct 2, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next